Navigation Links
Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
Date:3/1/2010

SAN DIEGO, March 1 /PRNewswire/ -- The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST).  The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.  Research at Pangu BioPharma and aTyr Pharma showed that these naturally occurring splice variants result in resected proteins ("resectins") that have functions distinct from the normal protein synthesis activities associated with tRNA synthetases.  These resectins perform a variety of extracellular signaling functions essential for normal human biology, and have the potential to be used as biotherapeutics in a variety of disease settings, including immunological, hematopoietic, neurological disorders, and inflammatory conditions.  The research at Pangu BioPharma is focused on identifying and characterizing new examples of the tRNA synthetases resectins arising from alternative splicing events, as well as on identifying their biological activities and potential applications as novel biotherapeutics.  The previous 18 month ITF award to Pangu BioPharma led to the building of a strong proprie
'/>"/>

SOURCE aTyr Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
2. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
3. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
4. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
8. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
9. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
10. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015  The departments of Drug and Alcohol ... Gaudenzia Concept 90 to raise awareness for International Overdose ... Pennsylvania and help more Pennsylvanians ... recovery through the Building Bridges to Recovery ... every day to a disease that is fully treatable, ...
(Date:8/31/2015)... -- Regen BioPharma, Inc. (OTCBB: RGBP) and (PINK: ... of delivering its patented (US Patent 8,263,571) gene ... a clinically approved formulation as delivery system.  The ... silencing therapeutics in which the gene silencing drug ... By utilizing a local delivery system, potential toxicities ...
(Date:8/31/2015)... TEL AVIV, Israel , August 31, 2015 ... Investments Ltd. (TASE: BOLT, OTCQX: BLGTY) ("BioLight" ... manages and commercializes biomedical innovations in ophthalmology and ... subsidiary, Micromedic Technologies (TASE: MCTC), has identified several ... necrosis of the jawbone in patients treated with ...
Breaking Medicine Technology:Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4
... Baby Girl with Hypophosphatasia Treated With ENB-0040 at Children,s ... , MONTREAL, Dec. 1 Enobia ... novel therapeutics for serious bone disorders, today announced that ... hypophosphatasia was dosed. Enobia is investigating Enzyme Replacement Therapy ...
... Genaera Corporation (Nasdaq: GENR ) today ... MSI-1436C-102 (Study 102), the multiple ascending dose Phase 1b ... 2 diabetics. MSI-1436 is a novel therapeutic for the ... centrally and peripherally to regulate insulin and leptin pathways ...
Cached Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3
(Date:8/31/2015)... ... August 31, 2015 , ... The Lisle family law ... William Scott has been nominated by his peers to earn a “Leading Lawyers” distinction. ... percent of attorneys in the state of Illinois. The nomination process is based on ...
(Date:8/31/2015)... ... August 31, 2015 , ... Patients who thought about ... who are interested in learning more about the procedure beyond the information found on ... Internationally recognized hair transplant surgeon Parsa Mohebi will be on hand to answer patients ...
(Date:8/31/2015)... ... September 01, 2015 , ... Neuropsychiatric Disease and Treatment ... on transcranial near-infrared laser phototherapy ”. , As corresponding author Dr Theodore Henderson ... untreatable - with mostly palliative treatments only - and now we have shown ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dr. Paul Kovatis of Orthopedic Spine & Sports ... Dr. Kovatis treats all surgical and non-surgical disorders of the leg, ankle and foot. ... system, excluding the spine. , Dr. Paul Kovatis completed his orthopedic leg, ankle and ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
Breaking Medicine News(10 mins):Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
... For the fourth,consecutive year, the Surf City USA(R) Marathon ... for a fundraising event that is directly,responsible for changing the ... In the Fourth Annual "Run for Mobility", ... Marathon and 5K as a way to raise funds,that sends ...
... general is boosting rates of obesity, other woes, experts ... a strong link between media exposure and childhood obesity, ... reviewed 173 studies on media and health conducted over ... 80 percent of the studies concluded that higher amounts ...
... "frozen lozenge" provides breakthrough method to help medicine go down , ... "A spoonful of sugar helps the medicine go down" -- parents ... Insight Pharmaceuticals has introduced Sucrets(R) ICE -- unique, frozen single-use packages ... sore throats. , , ...
... Med (IM) welcomes new CEO, S.,Hart Williford. Williford joins ... extensive background as a leader in healthcare,software, revenue management, ... Founder and nine-year CEO, Dr. ... and development in all sectors, as he steps into,the ...
... can affect whole families, experts point out , , TUESDAY, Dec. ... toll not only on women,s wallets but on their health ... back on health care due to costs, according to a ... Resource Center, part of the U.S. Department of Health and ...
... Science, and Technology at the Sandra Day O,Connor College ... international conference on April 3-4, 2009, in Tempe, Ariz., ... to the highly anticipated report of the U.S. National ... Sciences Community." , In addition to experts from ...
Cached Medicine News:Health News:Surf City USA(R) Marathon Impacts the World 2Health News:TV, Internet Causing Kids Harm: Report 2Health News:New Sucrets(R) ICE Cools Sore Throat Pain 2Health News:Ingenious Med Hires New CEO to Maintain and Further Expand Company Development 2Health News:Economy Driving Women to Skimp on Health Care: Poll 2Health News:Economy Driving Women to Skimp on Health Care: Poll 3
The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes...
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
... Provides quick freezing and quick ... gas system - cleans the ... Lightweight probe tips have high ... Retinal Detachment, Glaucoma and Intra-vitreal ...
... instant defrosting by reversible flow of gas ... cycle automatically. Lightweight probe tips have high ... I/A. The surgeon can select either of ... Surgeon can have a selection of Irrigation, ...
Medicine Products: